Kaplan SA - Search Results

1

Testosterone and benign prostatic hyperplasia.

Jarvis TR, Chughtai B, Kaplan SA. Jarvis TR, et al. Among authors: kaplan sa. Asian J Androl. 2015 Mar-Apr;17(2):212-6. doi: 10.4103/1008-682X.140966. Asian J Androl. 2015. PMID: 25337845 Free PMC article. Review.

2

Changing aspects in the evaluation and treatment of patients with benign prostatic hyperplasia.

Lam JS, Cooper KL, Kaplan SA. Lam JS, et al. Among authors: kaplan sa. Med Clin North Am. 2004 Mar;88(2):281-308. doi: 10.1016/S0025-7125(03)00147-0. Med Clin North Am. 2004. PMID: 15049579 Review.

3

Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype.

Walmsley K, Kaplan SA. Walmsley K, et al. Among authors: kaplan sa. J Urol. 2004 Oct;172(4 Pt 1):1249-55. doi: 10.1097/01.ju.0000129967.30558.ca. J Urol. 2004. PMID: 15371817 Review.

4

Benign prostatic hyperplasia: now we can begin to tailor treatment.

Gjertson CK, Walmsley K, Kaplan SA. Gjertson CK, et al. Among authors: kaplan sa. Cleve Clin J Med. 2004 Nov;71(11):857, 860, 863-5 passim. doi: 10.3949/ccjm.71.11.857. Cleve Clin J Med. 2004. PMID: 15570735 Free article. Review.

5

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.

Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: kaplan sa. Urology. 2004 Dec;64(6):1155-9. doi: 10.1016/j.urology.2004.07.018. Urology. 2004. PMID: 15596189 Clinical Trial.

6

Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.

Kaplan SA, Walmsley K, Te AE. Kaplan SA, et al. J Urol. 2005 Dec;174(6):2273-5. discussion 2275-6. doi: 10.1097/01.ju.0000181823.33224.a0. J Urol. 2005. PMID: 16280803

7

First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment?

Gonzalez RR, Kaplan SA. Gonzalez RR, et al. Among authors: kaplan sa. World J Urol. 2006 Sep;24(4):360-6. doi: 10.1007/s00345-006-0092-0. Epub 2006 May 19. World J Urol. 2006. PMID: 16710669 Review.

8

Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Gonzalez RR, Kaplan SA. Gonzalez RR, et al. Among authors: kaplan sa. Expert Opin Drug Metab Toxicol. 2006 Aug;2(4):609-17. doi: 10.1517/17425255.2.4.609. Expert Opin Drug Metab Toxicol. 2006. PMID: 16859408 Review.

9

Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia.

Kaplan SA. Kaplan SA. Rev Urol. 2006;8 Suppl 4(Suppl 4):S10-7. Rev Urol. 2006. PMID: 17215996 Free PMC article.

10

Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.

Kaplan SA. Kaplan SA. BJU Int. 2008 Nov;102 Suppl 2:3-7. doi: 10.1111/j.1464-410X.2008.08086.x. BJU Int. 2008. PMID: 19032603 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,014 results

Search Page

Filters